Polatuzumab vedotin

Ropolivy

BrazilCancelledAuthorised 23 Dec 2019

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Polatuzumab vedotin

Ropolivy

BrazilCancelledAuthorised 23 Dec 2019

Ask Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Polivy 140 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 140 mg · polvo para concentrado para solución para perfusión · Roche Registration Gmbh

Polivy 30 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 30 mg · polvo para concentrado para solución para perfusión · Roche Registration Gmbh

Polivy 140 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 140 mg · polvo para concentrado para solución para perfusión · Roche Registration Gmbh

PolivyItaly · Polvere per concentrato per soluzione per infusione · Roche Registration GMBH

Polivy 140 mg poeder voor concentraat voor oplossing voor infusieNetherlands · Poeder voor concentraat voor oplossing voor infusie · Roche Registration GmbH

Polivy®Serbia · 140mg · prašak za koncentrat za rastvor za infuziju · Roche DOO Beograd

Polivy®Serbia · 30mg · prašak za koncentrat za rastvor za infuziju · Roche DOO Beograd

Polivy Powder for Concentrate for Solution for Infusion 140MGSingapore · 140 mg · injection, powder, lyophilized, for solution · Roche Singapore Pte. LTD.

Polivy Powder for Concentrate for Solution for Infusion 30MGSingapore · 30mg/vial · injection, powder, lyophilized, for solution · Roche Singapore Pte. LTD.

PolivyUnited States · 140MG/VIAL, 30MG/VIAL · powder · Genentech

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Anvisa, Brazil

Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.

Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Polatuzumab vedotin
Register: Brazil (Anvisa)
Status: Cancelled
Status in the register: Inativo
Authorised: 23 Dec 2019
Registration: 101000669
Marketing authorisation holder: Produtos Roche Químicos e Farmacêuticos S.A.
Procedure: Registered